Weisert, Molly
Su, Jennifer A.
Menteer, Jondavid
Shaddy, Robert E.
Kantor, Paul F. http://orcid.org/0000-0003-3071-9289
Article History
Accepted: 8 November 2021
First Online: 27 January 2022
Declarations
:
: No external funds were used in the preparation of this manuscript.
: Robert Shaddy and Paul Kantor have served as Consultants to Novartis. Molly Weisert, Jennifer Su, and Jondavid Menteer declare no potential conflicts of interest that might be relevant to this manuscript.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: All authors contributed to the study conception, design, drafting, and editing of the manuscript. The revised final draft of the manuscript was modified by Paul F. Kantor. All authors read and approved the final manuscript.